Alzheimer's disease and oxygen radicals:: new insights

被引:153
作者
Praticò, D [1 ]
机构
[1] Univ Penn, Sch Med, Ctr Expt Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
Alzheimer's disease; oxygen free radicals; oxidative stress; isoeicosanoids; amyloid; transgenic animals;
D O I
10.1016/S0006-2952(01)00919-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's disease (AD) is the most common form of neurodegenerative disease, with dementia, in the elderly. In addition to the presence of senile plaques and neurofibrillary tangles, the AD brain exhibits evidence for oxygen radical-mediated damage, a situation commonly known as oxidative stress. However, the ability to directly implicate this mechanism in AD has been a difficult task for several reasons. First, most of the analytical approaches used to investigate oxidative stress turned out to be unreliable. Second, the majority of the published studies have been performed in post-mortem tissues with advanced disease, leaving open the question as to whether oxidative stress is an early event or a common final step secondary to the degenerative process. The discovery of the isoprostanes, recent studies performed in living patients, and the development of transgenic animal models of AD-amyloidosis are three important factors that are helping us to better understand and define the role that oxygen radicals might play in AD pathogenesis. Here we review some of the most recent works that have supported the importance of oxygen radical-mediated damage in AD. The accumulated information points toward an earlier involvement than previously thought of oxidative stress in the pathogenesis of the disease, making this a potential target for therapeutic intervention, especially in subjects at high risk for developing AD. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 38 条
[1]   NO EVIDENCE FOR SYSTEMIC OXIDANT STRESS IN PARKINSONS OR ALZHEIMERS-DISEASE [J].
AHLSKOG, JE ;
UITTI, RJ ;
LOW, PA ;
TYCE, GM ;
NICKANDER, KK ;
PETERSEN, RC ;
KOKMEN, E .
MOVEMENT DISORDERS, 1995, 10 (05) :566-573
[2]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[3]   Oxidative stress and Alzheimer disease [J].
Christen, Y .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (02) :621S-629S
[4]  
Clark CM, 2000, NEURODEGENERATIVE DE, P95, DOI DOI 10.1155/2016/258
[5]   THE NEUROBIOLOGICAL CONSEQUENCES OF DOWN-SYNDROME [J].
COYLE, JT ;
OSTERGRANITE, ML ;
GEARHART, JD .
BRAIN RESEARCH BULLETIN, 1986, 16 (06) :773-787
[6]   Antioxidants, oxidative stress, and degenerative neurological disorders [J].
Floyd, RA .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :236-245
[7]  
GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819
[8]   THE MEASUREMENT AND MECHANISM OF LIPID-PEROXIDATION IN BIOLOGICAL-SYSTEMS [J].
GUTTERIDGE, JMC ;
HALLIWELL, B .
TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (04) :129-135
[9]   Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice [J].
Hsiao, K ;
Chapman, P ;
Nilsen, S ;
Eckman, C ;
Harigaya, Y ;
Younkin, S ;
Yang, FS ;
Cole, G .
SCIENCE, 1996, 274 (5284) :99-102
[10]   Transgenic mouse models of Alzheimer's disease [J].
Janus, C ;
Chishti, MA ;
Westaway, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01) :63-75